Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

2.87
+0.07002.50%
Post-market: 2.870.00000.00%16:10 EDT
Volume:826.63K
Turnover:2.35M
Market Cap:265.97M
PE:-19.85
High:2.90
Open:2.79
Low:2.76
Close:2.80
52wk High:10.40
52wk Low:2.26
Shares:92.67M
Float Shares:87.17M
Volume Ratio:0.66
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1446
EPS(LYR):-0.5438
ROE:-12.80%
ROA:-9.70%
PB:2.37
PE(LYR):-5.28

Loading ...

Exploring High Growth Tech Stocks In The US Market May 2026

Simply Wall St.
·
May 28

North American Morning Briefing: Oil Rises After Fresh Attacks on Iran

Dow Jones
·
May 26

U.S. Earnings Preview: Before Market Open May 26

Dow Jones
·
May 26

Anavex receives Nasdaq delinquency notice over late quarterly filing

Reuters
·
May 22

Anavex receives expected Nasdaq delinquency notification

TIPRANKS
·
May 22

Anavex delays filing quarterly Form 10-Q after missing deadline

Reuters
·
May 22

Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification

THOMSON REUTERS
·
May 22

U.S. Earnings Preview: Before Market Open May 19

Dow Jones
·
May 19

Top News Today: Stocks Mixed as Traders Await U.S.-Iran Updates

Dow Jones
·
May 19

Anavex options imply 6.3% move in share price post-earnings

TIPRANKS
·
May 19

Anavex Life Sciences Announces COO Departure Amid Restructuring

TIPRANKS
·
May 16

Anavex COO Felix Lauscher exits after interim CEO appointment

Reuters
·
May 16

Anavex Life Sciences files Form 3 for Interim CEO Terrie Kellmeyer

Reuters
·
May 15

Anavex delays filing quarterly report for March 31, 2026 quarter

Reuters
·
May 12

Anavex Life Sciences Corp expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 09

Anavex Life Sciences names Terrie Kellmeyer interim CEO, succeeding Missling

TIPRANKS
·
May 07

Anavex Life Sciences Names Interim CEO Amid Leadership Shift

TIPRANKS
·
May 06

Anavex names Terrie Kellmeyer interim CEO after Christopher Missling exit

Reuters
·
May 06

Press Release: Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer

Dow Jones
·
May 06

Anavex Life Sciences files Form 3 for director Axel Paeger

Reuters
·
May 02